Quantcast

Latest Alcohols Stories

Researchers Combine Graphene And Painkiller Receptor
2014-05-13 03:09:16

University of Pennsylvania Almost every biological process involves sensing the presence of a certain chemical. Finely tuned over millions of years of evolution, the body’s different receptors are shaped to accept certain target chemicals. When they bind, the receptors tell their host cells to produce nerve impulses, regulate metabolism, defend the body against invaders or myriad other actions depending on the cell, receptor and chemical type. Now, researchers from the University of...

2014-05-13 08:31:28

SAN DIEGO, May 13, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that the U.S. Office of Orphan Products Development at the Food and Drug Administration (FDA) has approved the transfer of sponsorship of the Orphan Drug Designation for intrathecal resiniferatoxin (RTX) in the treatment of intractable pain in end-stage disease from the...

2014-05-13 08:31:21

--Webcast and conference call today at 8:30 a.m. EDT-- WAYNE, Penn., May 13, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the three months ended March 31, 2014. First quarter highlights include: -- Initiated pivotal bioequivalence studies of Egalet-001; -- Received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Egalet-001, an abuse-deterrent,...

2014-05-13 08:30:57

DIEPENBEEK, Belgium, May 13, 2014 /PRNewswire/ -- Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma. Based on Amakem's 'Localized Drug Action' platform, AMA0076 is a highly potent locally-acting Rho Kinase (ROCK) inhibitor that has been designed to reduce intraocular pressure (IOP) by acting...

2014-05-13 08:24:29

DUBLIN, May 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vc4fjw/2ethylhexanol) has announced the addition of the "2-Ethylhexanol (2-EH) Market by Applications (Plasticizers, 2-EH Acrylate, 2-EH Nitrate, and Others) & Geography - Trends and Forecasts to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The global 2-Ethylhexanol market, has witnessed a significant growth in the past few years and this growth is...

2014-05-13 00:21:36

SAN DIEGO, May 13, 2014 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, announced today that it will participate in the scientific discussion focusing on fibrotic disease during the American Thoracic Society International Conference (ATS 2014) in San Diego, CA, May 16 - 21. Data will highlight research conducted with inhaled GP-101 for the treatment of idiopathic pulmonary fibrosis (IPF). Genoa's abstract can be accessed through the ATS...

2014-05-12 23:09:29

Wright & Schulte LLC Files Effexor Lawsuit on Behalf of an Ohio Woman Who’s Child Was Born with Birth Defects Allegedly Due to the Antidepressant Drug Effexor Columbus, OH (PRWEB) May 12, 2014 An Effexor lawsuit was filed by Wright & Schulte LLC on behalf of an Ohio woman whose child was born with birth defects allegedly because she took the SSRI antidepressant drug Effexor while she was pregnan t. This Effexor lawsuit was filed in the U.S. District Court, Northern District of...

2014-05-12 23:08:41

Pulmonary arterial hypertension – a deadly, incurable lung condition – is one of only sixteen disease states FDA will focus on during the first three years of the Patient Focused Drug Development Initiative. The meeting represents a historic opportunity for patient input. Silver Spring, MD (PRWEB) May 12, 2014 On Tuesday, May 13, the Food and Drug Administration and the Pulmonary Hypertension Association will host a unique conversation between FDA drug reviewers and pulmonary arterial...

2014-05-12 16:29:21

Cardiome to conduct conference call and webcast today, May 12, at 5:00 p.m. Eastern (2:00 p.m. Pacific)NASDAQ: CRME TSX: COM VANCOUVER, May 12, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the first quarter ended March 31, 2014. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP). All share and per...

2014-05-09 23:08:07

“Health And Beauty Benefits Of Carrot, Carrot Juice And Carrot Oil,” a new report on the website Vkool.com uncovers benefits of carrots on health and skin. Seattle, Wa (PRWEB) May 09, 2014 “Health And Beauty Benefits Of Carrot, Carrot Juice And Carrot Oil,” a new report created by Jhearts on the site Vkool.com shows benefits of carrots on health and skin, and detailed instructions on how to use them properly. In the first part of this report, people will discover why they should...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related